Summary
- Main use
- Improvement of nutritional status through amino acid supplementation (such as in malnutrition and before or after surgery)
- Who uses it
- Adults · Children
- Adult dosage
- ○ Adults: Administer a maximum of 1~1.5 g of total amino acids per kg of body weight per day by intravenous infusion. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a general rule, infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g of D-sorbitol.
- Children's dosage
- In children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate for administration.
Ingredients
- L-Isoleucine420mg / 100mL
- L-Leucine660mg / 100mL
- L-Lysine Hydrochloride400mg / 100mL
- L-Methionine440mg / 100mL
- L-Phenylalanine440mg / 100mL
- L-Threonine200mg / 100mL
- L-Tryptophan100mg / 100mL
- L-Valine480mg / 100mL
- Arginine400mg / 100mL
- Histidine200mg / 100mL
- Proline340mg / 100mL
- D-Sorbitol5000mg / 100mL
- Manufacturer
- Boryung Biopharma Co., Ltd.
Efficacy & effects
Improvement of nutritional status through amino acid supplementation (such as in malnutrition and before or after surgery)
- Hypoalbuminemia
- malnutrition
View approved original textHide original text
This medication is used to help supply amino acids to maintain nutritional balance in conditions such as hypoalbuminemia, malnutrition, and pre- and post-operative states.
Dosage and Administration
Adult dosage
○ Adults: Administer a maximum of 1~1.5 g of total amino acids per kg of body weight per day by intravenous infusion. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; as a general rule, infuse at a rate of 80~130 drops per minute. However, the maximum daily dose is 100g of D-sorbitol.
Children's dosage
In children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate for administration.
Precautions
This drug should be used strictly under the supervision of a doctor and should not be taken or used independently. Do not administer this drug to patients with hepatic coma or at risk, those with severe renal impairment, or those with certain metabolic disorders. It should also be avoided in patients with severe heart failure, pulmonary edema, oliguria or anuria, and electrolyte imbalances such as hypernatremia. In cases of lactic acidosis or methanol poisoning, as well as those with hereditary fructose intolerance, administration is contraindicated based on the ingredients of this drug. Caution is also needed for patients with heart-related diseases, atrioventricular block, and severe myasthenia gravis. This drug should be administered carefully to patients with impaired liver or kidney function, severe acidosis, or congestive heart failure, and those with abnormalities in sodium or potassium levels. Contains sodium bisulfite, which can cause allergic reactions or asthma attacks, so patients with asthma should be particularly cautious. During use, side effects such as skin rash, nausea, vomiting, palpitations, and elevated blood pressure may occur, and in severe cases, breathing difficulties or shock may also arise. Rapid large doses can cause acidosis, so care should be taken with the administration speed and amount. Additionally, patients with impaired liver or kidney function may show abnormalities in blood tests, necessitating regular checks. When using this drug, care must be taken to maintain electrolyte balance, especially when used in conjunction with other electrolyte solutions. Safety has not been fully established for pregnant women, so it should only be used when the benefits of treatment outweigh the risks. In children, liver function may be immature, requiring lower dosages, and blood ammonia levels should be frequently monitored. In the elderly, physical functions are often diminished, so it is necessary to slow the administration speed and adjust the dosing. This medication should be administered slowly intravenously, as rapid administration can cause chills or vomiting. Before use, ensure the solution is clear and without abnormalities, and do not use if it is contaminated or discolored. Preparation and management of the injection device must be done in a sterile manner, and it should be stored in a sealed container at a proper temperature without opening the packaging.
Side effects
- skin rash
- nausea
- vomiting
- chest discomfort
- palpitations
- tachycardia
- elevated blood pressure
- acidosis
- feeling of heat
- vascular pain
Show 29 moreCollapse
- chills
- fever
- headache
- respiratory distress
- respiratory arrest
- shock
- bronchospasm
- ureteral spasm
- peripheral vascular dilation
- metabolic acidosis
- hypophosphatemia
- alkalosis
- hyperglycemia
- diabetes
- osmotic diuresis
- dehydration
- rebound hypoglycemia
- elevated liver enzymes
- vitamin deficiency
- vitamin excess
- electrolyte imbalance
- pediatric hyperammonemia
- elevated BUN
- serum amino acid imbalance
- metabolic alkalosis
- systemic nitrogenemia
- hyperammonemia
- loss of sensation
- coma
Not everyone experiences these, and they can vary from person to person.
Storage
This drug should be stored in a sealed container to prevent air and moisture from entering. The storage temperature should ideally be maintained between 1 and 30 degrees Celsius.
Appearance and packaging
Appearance
A colorless to pale yellow transparent solution contained in a colorless, transparent glass bottle with a rubber stopper for infusion.
Package unit
250mL/bottle x 1
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.